Frequently Asked Questions
Although Huntington’s disease typically manifests in adulthood, there is a less common form called Juvenile Huntington’s disease (or Juvenile HD). It affects children and adolescents, people who haven’t yet turned 20. Juvenile Huntington’s has its own distinct symptoms and progression.
Genetic testing can identify whether an individual carries the genetic mutation responsible for Huntington’s disease. However, the test cannot predict the age of onset or the specific symptoms an individual will experience.
The life expectancy of individuals with Huntington’s disease can vary significantly. It is influenced by factors such as the age at which symptoms begin and the overall management of the disease.
On average, individuals with Huntington’s disease live for approximately 15 to 20 years after the onset of symptoms. However, it is important to note that this is an average and individual cases can vary.
Research is continuously advancing our understanding of the disease and its impact on life expectancy. Ongoing studies aim to determine the extent of variation in life expectancy and the factors that contribute to it, including the causes of death.
The NDIS offers support and services tailored to the specific needs of individuals with Huntington’s disease.
This includes access to housing options like SDA, STA, complex care, and assistance with daily living tasks through Supported Independent Living (SIL). The NDIS also provides funding for assistive technology, respite care, and therapies that enhance independence and overall well-being.